Cargando…
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial
BACKGROUND: Erythropoiesis stimulating agent (ESA)-resistant anemia is common in chronic kidney disease (CKD). OBJECTIVES: To evaluate the determinants of severity of ESA resistance in patients with CKD and primary ESA-resistance. DESIGN: Secondary analysis of a randomized controlled trial (the Hand...
Autores principales: | Badve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., Johnson, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538753/ https://www.ncbi.nlm.nih.gov/pubmed/26284153 http://dx.doi.org/10.1186/s40697-015-0066-5 |
Ejemplares similares
-
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network
por: Morrish, Alicia T, et al.
Publicado: (2014) -
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
por: Lioufas, Nicole, et al.
Publicado: (2019) -
Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial
por: Johnson, David Wayne, et al.
Publicado: (2008) -
Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study
por: Zhan, Zhipeng, et al.
Publicado: (2019) -
Alkaline Phosphatase and Hypophosphatasia
por: Millán, José Luis, et al.
Publicado: (2015)